Muhammad Waqas Sadiq

Author

AstraZeneca (Sweden)ORCID

Also Known As

M W Sadiq, M.W. Sadiq, MW Sadiq, Muhammad W. Sadiq, Muhammad Waqas Sadiq

Publications

532

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (Sweden)Uppsala University AstraZeneca (Finland)AstraZeneca (United States)AstraZeneca (Switzerland)

About

Muhammad Waqas Sadiq is an author at AstraZeneca (Sweden) specializing in pharmacology, medicine, and molecular pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	175
2	Pharmacology	3	3	175
3	Neuroscience	2	2	142
4	Health Sciences	1	1	35
5	Biochemistry	1	1	35

Muhammad Waqas Sadiq

Publications

507

Citations

H-Index

Page 1

	Year	Citations
Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine Leif Carlsson, Jonathan Clarke, Christopher Yen, Molecular Therapy — Methods & Clinical Development	2018	167
Diphenhydramine Active Uptake at the Blood–Brain Barrier and Its Interaction with Oxycodone in vitro and in Vivo Muhammad Waqas Sadiq, Annika Borgs, Takashi Okura, Journal of Pharmaceutical Sciences Molecular PharmacologyDiphenhydramine Active UptakeBlood–brain BarrierMedicineNeuropharmacology	2011	107
A whole-body physiologically based pharmacokinetic (WB-PBPK) model of ciprofloxacin: a step towards predicting bacterial killing at sites of infection Muhammad Waqas Sadiq, Elisabet I. Nielsen, Dalia Khachman, Journal of Pharmacokinetics and Pharmacodynamics	2016	43
A Randomized Phase I Study of the Anti‐Interleukin‐33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease Fred Reid, Dave Singh, Muna Albayaty, Clinical Pharmacology & Therapeutics	2023	37
Validation of a P-Glycoprotein (P-gp) Humanized Mouse Model by Integrating Selective Absolute Quantification of Human MDR1, Mouse Mdr1a and Mdr1b Protein Expressions with In Vivo Functional Analysis for Blood-Brain Barrier Transport Muhammad Waqas Sadiq, Yasuo Uchida, Yutaro Hoshi, PLoS ONE Neurochemical BiomarkersExperimental PharmacologySelective Absolute QuantificationTranslational PharmacologyMolecular Pharmacology	2015	35
Oxymorphone Active Uptake at the Blood–Brain Barrier and Population Modeling of its Pharmacokinetic–Pharmacodynamic Relationship Muhammad Waqas Sadiq, Emma Boström, Ron J. Keizer, Journal of Pharmaceutical Sciences Pharmacokinetic ModelingBlood–brain BarrierMedicinePhysiologyPopulation Modeling	2013	33
Lung pharmacokinetics of inhaled and systemic drugs: A clinical evaluation Muhammad Waqas Sadiq, Olaf Holz, Birthe Ellinghusen, British Journal of Pharmacology	2021	33
Prediction of lisinopril pediatric dose from the reference adult dose by employing a physiologically based pharmacokinetic model Memoona Rashid, Muhammad Sarfraz, Mosab Arafat, BMC Pharmacology and Toxicology	2020	14
Morphine Brain Pharmacokinetics at Very Low Concentrations Studied with Accelerator Mass Spectrometry and Liquid Chromatography-Tandem Mass Spectrometry Muhammad Waqas Sadiq, Mehran Salehpour, Niklas Forsgard, Drug Metabolism and Disposition	2010	13
Characterisation of pharmacokinetics, safety and tolerability in a first‐in‐human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease Muhammad Waqas Sadiq, Sara Asimus, Maria G. Belvisi, British Journal of Clinical Pharmacology	2021	13

Page 1